INMD - INMD CLASS ACTION – Lead Plaintiff Deadline Approaching; Contact Robbins LLP for Information | Benzinga
SAN DIEGO, March 05, 2024 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a shareholder filed a class action on behalf of purchasers of InMode Ltd. (NASDAQ:INMD) common stock between June 4, 2021 and October 12, 2023. InMode produces medical equipment, including devices purporting to offer body sculpting and other rejuvenation technologies.
For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003.
The Allegations: According to the complaint, defendants made material misrepresentations and omissions regarding the price at which InMode sold its devices, as well as InMode's compliance with U.S. Food and Drug Administration regulations. Specifically, defendants failed to disclose that: (i) the Company heavily discounts almost every device it sells; (ii) demand for the Company's products was driven by InMode's willingness to discount its products; (iii) the Company violated FDA regulations by engaging in off-label marketing and promoting products for treatment of indications for which they lack FDA approval; and (iv) the Company violated FDA regulations by failing to timely report injuries caused by its devices.
Plaintiff alleges that the truth of InMode's misstatements began to emerge just before the market closed on February 17, 2023, when an investigative publication revealed ...